Lalitha Guruprasad

8PUBLICATIONS
1CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsCheminformatics and quantitative structure-activity relationshipsStructural biology (incl. macromolecular modelling)Sequence analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 06, 2025
Hexagonal Boron Nitride Nanoparticles for Inhibition of Small Fragment Tau Aggregation.

Srijita Paul, Lalitha Guruprasad

|Dec 17, 2024
Computational design and validation of small molecule inhibitors for type III phosphatidylinositol-4-kinase alpha, a hepatitis C drug target.

Jishu Pagag, Priyanka Andola, Laxman Durgam

|Dec 16, 2024
In silico design, modelling and molecular mechanisms of Axl receptor tyrosine kinase inhibitors.

Gatta K R S Naresh, Lalitha Guruprasad

|Sep 15, 2023
Mutational analyses, pharmacophore-based inhibitor design and in silico validation for Zika virus NS3-helicase.

Laxman Durgam, Jishu Pagag, Y Indra Neela

|Jan 02, 2023
Dynamic conformational states of apo, ATP and cabozantinib bound TAM kinases to differentiate active-inactive kinetic models.

Gatta K R S Naresh, Lalitha Guruprasad

|Jul 11, 2022
Fragment-based inhibitor design for SARS-CoV2 main protease.

Priyanka Andola, Jishu Pagag, Durgam Laxman

Pageof 2

Frequent Collaborators

2 joint publications

Gatta K R S Naresh